14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CBIO
Delisted

Catalyst Biosciences Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.511
+0 (+0%)
At Close: Dec 14, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Fri, 26 Apr 2024

Trading levels for CBIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.511 .
R2 0.511 .
R1 0.511 .
Current price: 0.511
Support S1 0.511 .
S2 0.511 .
S3 0.511 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.550 7.57 %
R2 0.539 5.42 %
R1 0.530 3.66 %
Current price 0.511
Support S1 0.500 -2.21%
S2 0.431 -15.67%
S3 0.420 -17.86%

CBIO Predictions History

5 years ago
 JS predicted that CBIO for 2018-07-16 is going $13.15 (7.70%)

6 years ago
 JS predicted that CBIO for 2018-02-23 is going $26.16 (-1.84%)

6 years ago
 Moleo.Gharib.15518 predicted that CBIO for 2017-12-13 is going $8.73 (3.31%)

Rank:

6 years ago
 Justin predicted that CBIO for 2017-12-13 is going $8.66 (2.49%)

Rank:

6 years ago
 Balagurubaran predicted that CBIO for 2017-12-13 is going $8.50 (0.59%)

Rank:

6 years ago
 Christopher.Savinon.15669 predicted that CBIO for 2017-12-13 is going $7.24 (-14.32%)

Rank:

6 years ago
 JS predicted that CBIO for 2017-06-27 is going $4.64 (3.80%)

6 years ago
 JuanC Villegas predicted that CBIO for 2017-06-27 is going $4.55 (1.79%)

6 years ago
 JS predicted that CBIO for 2017-06-05 is going $4.20 (0.72%)

6 years ago
 Sil predicted that CBIO for 2017-06-05 is going $7.42 (71.76%)

Rank:
Click to get the best stock tips daily for free!

About Catalyst Biosciences

Catalyst Biosciences Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT